Evidence-based Medicine
New guidelines to improve reporting standards of studies that investigate causal mechanisms.
28 Sep, 2021 | 09:00h | UTCNews release: New guidelines to improve reporting standards of studies that investigate causal mechanisms – University of Oxford
Original article: A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement – JAMA (free for a limited period)
Commentary: Reporting Findings From Mediation Analyses – JAMA (free for a limited period)
Commentary on Twitter (thread – click for more)
✨NEW✨ "A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies – The AGReMA statement" is now available @JAMA_current pic.twitter.com/nrt6grhomP
— Hopin Lee (@hopinlee) September 21, 2021
Opinion | Inappropriate Mixing Clinical and Systemic Thinking: Vaccines in the Young.
26 Sep, 2021 | 22:07h | UTCInappropriate Mixing Clinical and Systemic Thinking: Vaccines in the Young – Medium
Fraudulent ivermectin studies open up new battleground between science and misinformation.
26 Sep, 2021 | 22:08h | UTC
Video: Understanding noninferiority trials: purpose, power, and pitfalls.
26 Sep, 2021 | 21:39h | UTCOn Record: Understanding Noninferiority Trials: Purpose, Power, and Pitfalls – TCTMD
Expert panel recommends against use of race in assessment of kidney function.
24 Sep, 2021 | 09:01h | UTCExpert panel recommends against use of race in assessment of kidney function – STAT
Commentary on Twitter
A Unifying Approach for GFR Estimation: Recommendations of the @nkf – @ASNKidney Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease https://t.co/0qt8F7l9Wm (FREE)#KidneyDisease #HealthEquity pic.twitter.com/QVkMnsBA6B
— AJKD (@AJKDonline) September 23, 2021
Landmark articles suggest eliminating race in the estimation of kidney function.
24 Sep, 2021 | 09:03h | UTCStudy 2: Race, Genetic Ancestry, and Estimating Kidney Function in CKD – New England Journal of Medicine
Commentaries:
Remove Race From Equation Used to Assess Kidney Function, Researchers Say – AJMC
Commentary on Twitter
Honored to contribute to the NEW 2021 CKD-EPI #race-free #eGFR equation in our latest research published in @NEJM today. I learned a ton about equations. Importantly, the main lesson is that #race should NOT be incorporated into #biological tools. https://t.co/RvfWWwGOox pic.twitter.com/Xub23AUXht
— Amaka Eneanya, MD, MPH (@AmakaEMD) September 23, 2021
Cochrane Special Collection | De-implementation of low-value health care: resource prioritization in the COVID-19 pandemic era.
23 Sep, 2021 | 10:13h | UTCEditorial: Making wise choices about low‐value health care in the COVID‐19 pandemic – Cochrane Library
Commentary: Choosing health care wisely when resources are scarce – Evidently Cochrane
Commentaries on Twitter
?Our new editorial @cochranecollab: Making wise choices about low‐value health care in the COVID‐19 pandemic?https://t.co/qABVg7emRi
Linked Special Collection on low-value care: https://t.co/fstV8P8OQS#FreeAccess pic.twitter.com/h9KZGUm2kp
— Juan Franco ?️? (@juan_francomd) September 22, 2021
Sadly, some medical interventions are in use despite evidence against them. With @Cochrane_SH, we have published a Special Collection of Cochrane reviews of Low Value Care interventions and described the issue in an Editorial. We cannot afford wasted HC. https://t.co/PXUhaMZud2
— Karsten Juhl Jørgensen (@KarstenJuhl) September 22, 2021
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.
23 Sep, 2021 | 10:08h | UTC
Commentary on Twitter
Flaws in ivermectin data suggest that COVID-19 meta-analyses need rethinking
Correspondence from Jack Lawrence @GidMK @K_Sheldrick and colleagues https://t.co/lUqXX9DQjO pic.twitter.com/Oh848X1VGv
— Nature Medicine (@NatureMedicine) September 22, 2021
Effectiveness and Ethics of Incentives for Research Participation: 2 Randomized Clinical Trials.
21 Sep, 2021 | 08:57h | UTCEffectiveness and Ethics of Incentives for Research Participation: 2 Randomized Clinical Trials – JAMA Internal Medicine (free for a limited period)
Editorial: Evidence for the Ethics of Incentivizing Clinical Trial Enrollment? – JAMA Internal Medicine
Commentary on Twitter
In this study, financial incentives increased trial enrollment in one of two trials, and did not produce undue or unjust inducement or other unintended consequences in either trial https://t.co/SaCk1XinuO
— JAMA Internal Medicine (@JAMAInternalMed) September 20, 2021
Editorial: Authorship and Publication Matters: Credit and Credibility.
21 Sep, 2021 | 08:54h | UTCAuthorship and Publication Matters: Credit and Credibility – Anesthesiology
Related: When is ‘self-plagiarism’ OK? New guidelines offer researchers rules for recycling text – Science
Commentary on Twitter
Anesthesiology editors focus on authorship and publication matters in a recent editorial examining journal policies on appropriate recognition for authors and collaborators. https://t.co/2NCpTEkpQW#PeerReviewWeek21 pic.twitter.com/lYtXtZD0l9
— Anesthesiology journal (@_Anesthesiology) September 20, 2021
Side effect patterns in a crossover trial of statin, placebo, and no treatment – This N-of-1 trial, now published in full, suggests the nocebo effect causes most of statins muscle adverse effects.
19 Sep, 2021 | 23:30h | UTC
Editorial: Striving for diversity in research studies.
16 Sep, 2021 | 10:02h | UTCStriving for Diversity in Research Studies – New England Journal of Medicine
How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines.
16 Sep, 2021 | 09:56h | UTC
Ivermectin: Cochrane’s most talked about review so far, ever. Why?
15 Sep, 2021 | 09:07h | UTCIvermectin: Cochrane’s most talked about review so far, ever. Why? – Cochrane Library
Original review: Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.
Commentary on Twitter
Ivermectin: Cochrane’s most talked about review so far, ever. Why?https://t.co/KmOLR9qHrF#ivermectin #evidencesynthesis #systematicreviews #COVID19 #Cochrane #publichealth #globalhealth #medicine pic.twitter.com/twLyqzSrcF
— Cochrane US Network (@Cochrane_US) September 14, 2021
Opinion | Don’t make early career researchers ‘ghost authors.’ Give us the credit we deserve.
14 Sep, 2021 | 08:50h | UTCDon’t make early career researchers ‘ghost authors.’ Give us the credit we deserve – Science
Face masks for COVID pass their largest test yet – “A rigorous study finds that surgical masks are highly protective, but cloth masks fall short”.
10 Sep, 2021 | 05:36h | UTCFace masks for COVID pass their largest test yet – Nature
Original study: [Preprint] Largest study of masks yet details their importance in fighting Covid-19.
Commentary on Twitter
Face masks for COVID pass their largest test yet – I & others comment. It is true that I bought pink surgical masks (my favorite color) in response to this study for when I am around unvaccinated adults (or indoor public spaces for now)https://t.co/nFhlcqwrjv
— Monica Gandhi MD, MPH (@MonicaGandhi9) September 9, 2021
Perspective | Rethinking medication adherence.
9 Sep, 2021 | 08:55h | UTCRethinking Medication Adherence – Therapeutics Initiative
Opinion | Video: Immunity is the only way through a pandemic (w/Dr. Monica Gandhi).
7 Sep, 2021 | 10:45h | UTCImmunity Is The Only Way Through A Pandemic (w/Dr. Monica Gandhi) – ZDoggMD
Opinion | “The downsides of masking young students are real”.
3 Sep, 2021 | 10:24h | UTCThe Downsides of Masking Young Students Are Real – The Atlantic
Commentary with a rebuttal on Twitter (thread – click for more)
I'm not greatly interested in the school/mask debate, but I must say this is pretty wild – the article leads with this statement and then proceeds to offer no evidence whatsoever of any harms except "subjective [sic] shortness of breath" https://t.co/JL1Iadt8fy pic.twitter.com/5bZmvOhWo7
— Health Nerd (@GidMK) September 2, 2021
Drowning in the literature? These smart software tools can help.
3 Sep, 2021 | 10:09h | UTCDrowning in the literature? These smart software tools can help – Nature
EBM Learning | How to create PICO questions about diagnostic test. In this paper, the author presents an example of a PICO for a question about test accuracy and an example of a PICO for a question about the effects of care with a test.
2 Sep, 2021 | 08:18h | UTCHow to create PICO questions about diagnostic test – BMJ Evidence-Based Medicine
Opinion | COVID vaccines: we need to find out which incentives actually work – the author argues that policies to promote vaccine uptake should be tested in randomized clinical trials.
31 Aug, 2021 | 08:56h | UTCCOVID vaccines: we need to find out which incentives actually work – The Conversation
Guide to Statistics and Methods: Interpreting the ACC/AHA clinical practice guideline recommendation classification system.
25 Aug, 2021 | 08:46h | UTCInterpreting the ACC/AHA Clinical Practice Guideline Recommendation Classification System – JAMA (free for a limited period)
Digital transformation of major scientific meetings induced by the COVID-19 pandemic: insights from the ESC 2020 annual congress.
25 Aug, 2021 | 08:35h | UTC
Commentary on Twitter
One of the COVID-19 induced challenges: How to run a major scientific online meeting as the annual European Society of Cardiology congress with >125.000 registrants?! Read all about it in EHJ – Digital Health https://t.co/Zv2pu6vv5n@escardio @ProfMartinCowie @rafavidalperez pic.twitter.com/utgsebYMoB
— Nico Bruining (@BruiningNico) August 23, 2021
Opinion | The FDA really did have to take this long – “If vaccine approval feels maddeningly scrupulous, that’s because the alternative is worse”.
24 Aug, 2021 | 10:01h | UTCThe FDA Really Did Have to Take This Long – The Atlantic